INTERNATIONAL PATENT: INCYTE CORPORATION, SMITH, PAUL FILES APPLICATION FOR "RUXOLITINIB FOR USE IN THE TREATMENT OF PRURIGO NODULARIS"

GENEVA, May 14 -- INCYTE CORPORATION (1801 Augustine Cut-OffWilmington, Delaware 19803), SMITH, Paul (c/o Incyte Corporation1801 Augustine Cut-OffWilmington, Delaware 19803) filed a patent application (PCT/US2024/053320) for "RUXOLITINIB FOR USE IN THE TREATMENT OF PRURIGO NODULARIS" on Oct 29, 2024. With publication no. WO/2025/096373, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): INCYTE CORPORATION (1801 Augustine Cut-OffWilmington, Delaware 19803), SMITH, Paul (c/o Incyte Corporation1801 Augustine Cut-OffWilmington, ...